当正确估算成为可能时,为何仍会高估或低估慢性肾脏病?
本文以摩洛哥成人随机代表性样本(应答率85%)严格应用KDIGO指南的患病率研究为例,指出仅用eGFR<60 mL/min/1.73 m2单一阈值分类CKD 3-5期会在>55岁人群造成过度诊断、在较年轻且eGFR>60 mL/min/1.73 m2但低于同龄同性别第三百分位者造成漏诊,采用年龄-性别特异性eGFR第三百分位作为切点可识别这些假阳性与假阴性。
要点
- 严格应用KDIGO指南并确认蛋白尿与eGFR慢性性后,摩洛哥成人CKD患病率为2.9%。
- 仅用eGFR<60 mL/min/1.73 m2单一阈值会在>55岁人群造成明显过度诊断。
- 采用年龄-性别特异性eGFR第三百分位作切点可识别假阳性与假阴性。
核心结论
- 亟需按正确方式应用近期KDIGO指南开展更多高质量的CKD患病率研究,以避免对CKD真实疾病状态的高估达≥50%并带来潜在严重后果。
研究设计与样本
- Maremar(maladies rénales chroniques au Maroc)为已发表的摩洛哥成人CKD、高血压、糖尿病与肥胖患病率研究,采用随机、代表性且应答率85%的样本,并严格应用KDIGO指南。
主要发现
- 按摩洛哥2015年实际成人人口调整后,CKD患病率较低,为2.9%。
- 该低患病率的部分原因包括Maremar人群呈塔吉锅样人口金字塔,以及确认初筛所见的蛋白尿并证实eGFR下降的慢性性,从而排除假阳性结果。
- 采用eGFR<60 mL/min/1.73 m2这一任意单一阈值分类CKD 3、4、5期,会在>55岁人群、尤其无蛋白尿、血尿或高血压者中造成明显过度诊断(假阳性)。
- 该单一阈值还会在eGFR>60 mL/min/1.73 m2且低于其年龄/性别类别第三百分位的较年轻个体中造成明显漏诊(假阴性)。
- 采用基于年龄-性别特异性eGFR参考值的第三百分位eGFR水平作为切点,可识别这些假阳性与假阴性。
关键数值与推荐
- CKD患病率8-13%见于世界不同地区的若干近期研究。
- 按摩洛哥2015年实际成人人口调整后CKD患病率为2.9%。
- 以eGFR<60 mL/min/1.73 m2单一阈值分类CKD 3、4、5期。
- 以年龄-性别特异性eGFR参考值的第三百分位作为切点。
临床怎么用
- 原文未据此给出推荐。
局限性
- 一些社论与综述已开始描述相当数量研究的弱点。
- Maremar人群呈塔吉锅样人口金字塔是低患病率的一个因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is no doubt that the introduction of the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines 14 years ago, and their subsequent updates, have substantially contributed to the early detection of different stages of chronic kidney disease (CKD). Several recent studies from different parts of the world mention a CKD prevalence of 8-13%. However, some editorials and reviews have begun to describe the weaknesses of a substantial number of studies. Maremar (maladies rénales chroniques au Maroc) is a recently published prevalence study of CKD, hypertension, diabetes and obesity in a randomized, representative and high response rate (85%) sample of the adult population of Morocco that strictly applied the KDIGO guidelines. When adjusted to the actual adult population of Morocco (2015), a rather low prevalence of CKD (2.9%) was found. Several reasons for this low prevalence were identified; the tagine-like population pyramid of the Maremar population was a factor, but even more important were the confirmation of proteinuria found at first screening and the proof of chronicity of decreased estimated glomerular filtration rate (eGFR), eliminating false positive results. In addition, it was found that when an arbitrary single threshold of eGFR (<60 mL/min/1.73 m2) was used to classify CKD stages 3, 4 and 5, it lead to substantial 'overdiagnosis' (false positives) in the elderly (>55 years of age), particularly in those without proteinuria, haematuria or hypertension. It also resulted in a significant 'underdiagnosis' (false negatives) in younger individuals with an eGFR >60 mL/min/1.73 m2 and below the third percentile of their age-/gender-category. The use of the third percentile eGFR level as a cut-off, based on age-gender-specific reference values of eGFR, allows the detection of these false positives and negatives. There is an urgent need for additional quality studies of the prevalence of CKD using the recent KDIGO guidelines in the correct way, to avoid overestimation of the true disease state of CKD by ≥50% with potentially dramatic consequences.
引用
- De Broe ME, Gharbi MB, Zamd M, et al. Why overestimate or underestimate chronic kidney disease when correct estimation is possible? Nephrol Dial Transplant. 2017. PMID: 28380639. doi:10.1093/ndt/gfw267
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。